Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.700
-0.110 (-3.91%)
At close: Jul 21, 2026, 4:00 PM EDT
2.700
0.00 (0.00%)
After-hours: Jul 21, 2026, 4:10 PM EDT
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $6.19 million as of July 21, 2026. Its market cap has increased by 10.46% in one year.
Market Cap
6.19M
Enterprise Value
-1.16M
1-Year Change
10.46%
Ranking
Category
Stock Price
$2.70
ChartMarket Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $6.19M, a decrease of -87.03%. That is a compound annual growth rate of -18.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 6.19M | 23.72% |
| Dec 31, 2025 | 5.00M | -19.35% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
| Jun 30, 2016 | 47.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kairos Pharma | 6.89M |
| PharmaCyte Biotech | 6.69M |
| Acurx Pharmaceuticals | 6.66M |
| XTL Biopharmaceuticals | 6.47M |
| Ernexa Therapeutics | 6.33M |
| Evogene | 6.20M |
| Addex Therapeutics | 6.19M |
| BioAtla | 6.14M |